Citation Tools
PDFRegular and Young Investigator Award Abstracts
Clinical Trials Completed
596 Results from a phase 1 study of CDX-1140, a fully human anti-CD40 agonist monoclonal antibody (mAb), in combination with pembrolizumab
Download to a citation manager
Download the citation for this article by clicking on one of the following citation managers:
- Cite this article as:
- 596 Results from a phase 1 study of CDX-1140, a fully human anti-CD40 agonist monoclonal antibody (mAb), in combination with pembrolizumab